Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?
- 29 February 2000
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 73 (2) , 292-299
- https://doi.org/10.1016/s0015-0282(99)00510-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- A psychological analysis of menopausal hot flushesBritish Journal of Clinical Psychology, 1995
- The prevalence of menopausal symptoms in patients treated for breast cancerClinical Oncology, 1994
- The Royal Marsden Hospital pilot tamoxifen chemoprevention trialBreast Cancer Research and Treatment, 1994
- Hormone replacement therapy In breast cancerThe Lancet, 1993
- Hormone replacement after breast cancerThe Lancet, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Estrogen Replacement Therapy in Women with Breast Cancer: A Survey of Patient AttitudesThe Lancet Healthy Longevity, 1992
- Hormone replacement therapy in women treated for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989